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Abstract 
 
Background/Aim. Diagnosis of amyotrophic lateral 
sclerosis (ALS) is based on combination of clinical signs 
and electrophysiological correlates of pathological proc-
ess which takes place in general. New electrophysiologi-
cal criteria Awaji-Shima (AS) additionally qualify the 
complex fasciculations and neurogenically modified po-
tentials of motor units as signs of active lesions of pe-
ripheral motor neuron, contrary to previously valid re-
vised El Escorial criteria (rEE). The objective of this re-
search was to determine the clinical significance and ad-
vantages of using the AS criteria in patients with ALS. 
Methods. Thirty patients (59.2 ± 10.9 years, 57% of 
them with spinal form of the disease) with clinically 
suspected ALS were monitored from the time of diagno-
sis until reaching the category of definitive diagnosis or 
death. The clinical evaluation and electromyographic 
(EMG) examinations were carried out at 3-month inter-
vals. Results. By applying the AS criteria, the category 
of probable or definite diagnosis was achieved in all pa-
tients with ALS, except in one (96.6%), as contrary to 
the rEE (33.3%), after 6 months of the follow-up period. 
The subclinical affection in more than two body regions 
has been defined through detection of denervation po-
tentials (80% of the patients by using the AS, or 67% by 
the rEE criteria). The complex fasciculations were regis-
tered particularly often in small muscles of the feet (37–
40%). Conclusion. Application of the AS criteria im-
prove the achievment of category of probable or definite 
diagnosis of ALS by 2.7 months earlier compared to the 
rEE. This outcome is particularly affected by a higher fre-
quency of positive EMG findings, when the AS criteria 
were employed. Early determination of diagnosis provides 
the better perspective and more frequent participation of 
the ALS patients in pharmacotherapy studies intended to 
establish new therapeutic options. 
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Uvod/Cilj. Dijagnoza amiotrofične lateralne skleroze (LS) 
zasniva se na kombinaciji kliničkih znakova i elektro-
fizioloških korelata patološkog procesa koji se odvija u 
osnovi. Novi elektrofiziološki kriterijumi, Awaji-Shima 
(AS), dodatno kvalifikuju kompleksne fascikulacije i neu-
rogeno izmenjene potencijale motornih jedinica kao zna-
kove aktivnih lezija perifernog motornog neurona, nasu-
prot ranije važećim revidiranim El Escorial kriterijumima 
(rEE). Cilj ovog istraživanja bio je da se utvrdi klinički 
značaj i prednosti primene AS kriterijuma, kod obolelih od 
ALS. Metode. 30 bolesnika (59,2 ± 10,9 godina, od kojih 
57%  sa spinalnom formom bolesti) sa klinički suspektnom 
ALS, praćeno je od vremena postavljanja dijagnoze do po-
stizanja kategorije definitivne dijagnoze ili smrtnog ishoda. 
Kod bolesnika su obavljane klinička evaluacija i elektromi-
ografski (EMG) pregledi u tromesečnim intervalima. Re-
zultati. Primjenom AS kriterijuma, nakon 6 meseci 
praćenja, kategorija verovatne ili pouzdane dijagnoze po-
stignuta je kod svih bolesnika sa ALS, izuzev jednog 
(96,6%), nasuprot rEE kriterijuma (33.3%). EMG nalazi bi-
li su pozitivni u ≥ 2 telesna regiona kod 80% bolesnika 
primenom AS, odnosno 67% primenom rEE. Kompleksne 
fascikulacije zabeležene su posebno učestalo u malim 
mišićima stopala (37–40%). Zaključak. Primenom AS kri-
terijuma kategorija vjerovatne ili pouzdane dijagnoze ALS 
postiže se za 2,7 meseca ranije, u poređenju sa rEE, na šta 
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posebno utiče veća učestalost pozitivnih EMG nalaza. Ra-
nije utvrđivanje dijagnoze donosi perspektivu veće zastu-
pljenosti obolelih u farmakoterapijskim studijama sa no-
vim terapeutskim agensima. 
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Amyotrophic lateral sclerosis (ALS) is a fatal progres-
sive neurodegenerative disease caused by the selective dam-
ages of motor neurons of the cerebral cortex, brainstem and 
anterior horns of the spinal cord. The disease is clinically 
manifested by the combination of lesions of the central 
(CMN) and peripheral motor neuron (PMN) with progressive 
development of muscle weakness and atrophy 1. The diagno-
sis of ALS is based on the combination of neurological find-
ings and subclinical signs of PMN lesions, which are re-
vealed by electromyography (EMG) 2. 
During the evolution of diagnostic concept in ALS, 
several diagnostic approaches were applied, starting with 
Lambert criteria 3. Over time, a concept of diagnostic catego-
ries divided into suspected, probable and definite diagnosis 
of ALS has been established. Such probabilistic approach is, 
on one hand, based on a broad differential diagnosis of ALS, 
which requires high specificity, and on the other hand, on the 
fact that there is no biological surrogate marker of the dis-
ease which would facilitate the diagnosis. 
Furthermore, therapeutic options in the treatment of this 
disease are extremely modest, with a slight exception of a 
beneficial effect of the antiglutamatergic drug riluzole which 
affects the length of survival mainly in the categories of 
probable and definite ALS 4. Therefore, effective testing of 
the innovative pharmacological agents, with highly probable 
diagnosis as imperative, is limited to a small proportion of 
patients. In this way, the possibility of accepting incorrect 
diagnosis in the process of testing new drugs is substantially 
reduced and high credibility of the findings is ensured. 
However, by using the restrictive criteria (revised El 
Escorial – rEE criteria) based on a broad differential diagno-
sis of ALS, it is easy to understand that the sensitivity is sig-
nificantly reduced 5, 6. Therefore, in order to facilitate the di-
agnosis, in 2006 there was a modification of the rEE criteria, 
which were proposed to be called Awaji-Shima after the 
place of the meeting. New criteria, particularly emphasized 
the phenomena of complex fasciculations and neurogenically 
modified motor unit potentials which can be detected and 
analyzed by using the needle electromyography. These indi-
cators, especially the complex fasciculations, as it is sug-
gested, represent the electrophysiological correlates of acute 
denervation or additional markers of affected PMN. In that 
way, the number of EMG indicators increases, which in 
combination with the clinical signs of PMN lesions, in-
creases the sensitivity of Awaji diagnostic criteria 7. 
This research compared the difference between two sys-
tems of classification by using the rEE and Awaji-Shima cri-
teria in relation to the time required to achieve the category 
of probable and definitive diagnosis of ALS, and the time of 
initial evaluation on the reasonable suspicion of ALS (cate-
gory of suspected diagnosis). In addition to that, the study 
separately discussed the subclinical aspects of affected body 
regions based on the evaluation of electromyographic find-
ings and their impact on the achievement of specific catego-
ries of the disease according to either the rEE or Awaji-
Shima criteria and relation to the time course. 
The primary objective of the study was the time neces-
sary to determine the category of probable or reliable diag-
nosis of ALS, expressed in months. 
The secondary objective was the analysis of denerva-
tion potential frequency - the complex fasciculation in differ-






Sixty-eight patients with clinical presentation of pro-
gressive muscular weakness suggestive for ALS were exam-
ined at the Clinic of Neurology, University Hospital Clinical 
Centre Banja Luka, the Republic of Srpska, Bosnia and Her-
cegovina in the period 2012–2014. The suspected ALS was 
diagnosed in 30 patients (20 men, average age of 59.2 ± 10.9, 
ranging between 39–75 years). The analysis excluded patients 
with different forms of neuropathy (primarily those with multi-
focal motor neuropathy) and the patients with positive family 
history of motor neuron disease since the progression of spo-
radic and familiar forms of the disease are not the same. Demo-
graphic data of patients is presented in Table 1. 
Table 1  
Demographic and baseline clinical characteristics of patients with amyotrophic lateral sclerosis (ALS) at study entry  
Parameters Total sample  (n = 30) 
Spinal form 
(n = 17) 
Bulbar form 
(n = 13) p 
Age (years), mean (SD) 59.2 (10.2) 54.8 (10.8) 64.9 (8.8) 0.01 
(range) 39–75 39–71 45–75  
Gender (female) 10 2 8  
Time elapsed from symptom 
onset (months), mean (SD) 10.2 (4.5) 9.6 (4.8) 10.9 (4.0) n.s. 
(range) 3–18 5–18 4–18  
ALS-FRS, mean (SD) 43.3 (3.6) 41.8 (4.2) 46.1 (3.9) n.s. 
*ALS-FRS – ALS Functional Rating Scale; SD – standard deviation; n.s. – not significant. 
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When they entered the study, the patients were sub-
jected to clinical evaluation and electromyographic examina-
tion at 3-month intervals, either to achieve a category of 
definite diagnosis or death, if it occurred before reaching this 
category. 
At each visit to the Clinic, on the basis of the neu-
rologic findings and the EMG examination, currently af-
fected body regions in patients were defined (bulbar region, 
cervical, thoracic and lumbosacral spinal region) according 
to clinical signs of CMN and PMN lesions as well as the 
EMG correlates of the PMN lesions. Based on that evalua-
tion, the patients were categorized in accordance with the 
rEE and AS criteria (Table 2). Additionally, the assessment 
of functional score (FS) at each examination and for each pa-
tient was made using The Amyotrophic Lateral Sclerosis 




EMG was done with concentric disposable electrodes 
(TECA, 25 mm × 30G) on the equipment model Medelec 
Synergy (VIASIS, United Kingdom) by the same researcher 
under the same environmental conditions (the temperature of 
extremities 30°C), for muscles in the mentioned body re-
gions, according to the selection as follows:  bulbar region – 
one muscle [m. mentalis – mMEN (n. facialis)]; cervical spi-
nal region – three muscles [m. deltoideus – mDEL (C5-C6; n. 
axillaris), m. biceps brachii – mBB (C5-C6; n. musculocuta-
neus) and m. abductor digiti minimi – mADM (C8-Th1; n. 
ulnaris)]; thoracic spinal region: muscles in several segments  
[mm. paravertebrales toracales – mPV (Th2–Th10)]; lum-
bosacral spinal region – two muscles  [m. vastus lateralis – 
mVL (L2–L3–L4; n. femoralis), m. tibialis anterior – mTA 
(L4–L5–S1; n. peroneus), m. extensor digitorum brevis – 
mEDB (L5–S1; n. peroneus) and m. flexor hallucis brevis – 
mFHB (L5–S1; n. plantaris medialis grana n. tibialis)]. 
The signs of PMN lesion were considered to be the oc-
currence of a denervation potential type of fibrillation, posi-
tive sharp waves (PSW) and fasciculations if they were 
found in the target muscle in two or three locations during 
the relaxation. The neurogenic lesion was also indicated by 
the presence of changed motor unit action potential (MUAP) 
on the increase of amplitude pattern, extended duration and 
increased number of phases (poly-phases) and with the re-
duction of an interference pattern. The myotomal distribution 
was confirmed if the electrophysiological signs of the PMN 
lesion were registered in the muscles that were differently 




The data were analyzed by the method of descriptive 
and analytical data processing (Mann-Whitney U test, Chi-
square test, Fisher’s exact test, Wilcoxon signed-rank test). 
The time necessary for the achievement of the specific 
diagnostic categories of ALS was correlated with a number 
of EMG positive regions and the pattern of diagnosis (bulbar vs. 
spinal form) whenever the McNemar test was used. The results 
were presented as means ± standard deviation. Statistically sig-
nificant differences were considered if p-value < 0.05. 
Statistical analysis was done using the application for 




Initial clinical and electrophysiological examination in-
cluded 68 patients whereby the diagnosis of suspected ALS 
was confirmed in 30 patients. In other patients who were ini-
tially examined, the multifocal motor neuropathy was diag-
nosed in 5 patients, polyradiculopathy in 24 patients, para-
neoplastic neuropathy in 4 patients, spinal muscular atrophy 
in 3 patients and myositis in 2 patients. The initial clinical 
presentation of the spinal form of ALS was present in 17 
(57%) patients. Comparing the forms of disease in the tested 
sample, it was found that the patients with the bulbar form of 
the disease were about 10 years older (64.9 ± 8.8 vs. 54.8 ± 
10.8; p = 0.010) (Table 1). 
 
Table 2 
Comparative overview of the distribution and affected number of body regions necessary to diagnose the categories of 
amyotrophic lateral sclerosis (ALS) in accordance with rEE and AS criteria 
Parameters rEE criteria AS criteria 
 Possible ALS   
CMN 1 1 
PMN 1* 1 
Probable – laboratory  
supported ALS  
CMN 1  
PMN 1*  
Probable ALS    
CMN 2 2 
PMN 2* 2 
 Definite ALS   
CMN 3  
PMN 3  
CMN – central motor neuron; PMN – peripheral motor neuron; *The level of PMN lesion must be rostral in relation to CMN 
lesion along the neural axis (neuraxis); rEE – revised El Escorial criteria; AS – Awaji-Shima criteria. 
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Fig. 1 – Distribution of diagnostic categories by using  
the rEE or AS criteria according to the time intervals  
in which repeated evaluations were done (A – 3 months; 
B – 6 months; C – 9 months; D – 12 months). 
* p < 0.05, ** p < 0.01 (indicates the level of statistical 
significance); rEE – revised El Escorial criteria;  
AS – Awaji-Shima criteria; POSS – possibly;  
PROB – probably; DEF – definitely. 
 
Body regions in which the initial difficulties in the spi-
nal form of the disease were expressed, were evenly repre-
sented – there were 9 patients with the cervical and 8 with 
the lumbosacral clinical presentation. 
During the period of monitoring, 7 out of 30 patients 
diagnosed with ALS died in the interval between 10 and 14 
months after the first examination, so, after 12 months, it was 
possible to analyze 26 patients in total, and after 15 months, 
only 23 patients. 
According to the data obtained from an anamnestic in-
terview, the patients (> 2/3 examinees) took the first exami-
nation in the period between 6 and 24 months from the time 
of the subjective perception of symptoms, which were sub-
sequently confirmed as the correlates of lesions of the CMN 
and/or PMN (Table 1). 
The primary objective of the study, the time necessary to 
achieve the category of probable or definite diagnosis of ALS, 
was achieved in all patients in the period between 9 and 15 
months of monitoring, or after 4 or 6 repeated examinations (in-
cluding the initial). By using the rEE criteria, the average period 
necessary to achieve the category of probable and definite diag-
nosis was 9.4 months, while for the AS criteria, it was 6.7 
months which created a difference of 2.7 months. 
Accordingly, the target diagnostic categories (probable 
or definitive) by using rEE and AS criteria was achieved at 
different rates at successive time points as shown in Figure 1 
and Table 2. The key difference was generated in the second 
control examination (6 months after the initial evaluation), 
when applying rEE category probable (or definitive) diagno-
sis was achieved only in 1/3 of patients, as opposed to 96.6% 
when AS criteria were applied. This was also the key find-
ings of the study. 
However, when we analyzed the time required to 
achieve the target diagnostic categories in relation to the dis-
ease form (bulbar vs. spinal), the key difference was detected 
on the third examination (6 months after the initial one) 
showing that the AS reached the target for all ALS patients 
with bulbar form compared to less than half patients with 
spinal form (46.2%) (Figure 2). 
In an attempt to define the contribution of number of 
positive body regions, in which the contribution in the detec-
tion of PMN lesions was achieved by using the EMG for di-
agnostic categories of probable and definite diagnosis, there 
were distinguished findings – at the third examination (after 
6 months)  of the patients classified by using the rEE criteria, 
67% had positive EMG findings in 2 or more body regions, 
in contrast to 80% of patients classified by the AS criteria (p 
= 0.031) (Figure 3). A similar difference was determined by 
a number of patients, who at the fourth examination (in the 
ninth month of monitoring) showed the positive EMG find-
ings in three or more body regions according to the used cri-
teria (rEE = 42% vs. AS= 71%, p < 0.05) (Figure 3). 
The denervation potentials (fibrillation, PSW and complex 
fasciculations) were present in the patients with ALS with dif-
ferent frequency. The complex fasciculations were particularly 
frequent in small foot muscles, mEDB and mFHB (40% and 
37% respectively) at the third examination (in the sixth month of 
monitoring). Contrary to that, fibrillation and PSW were regis-
tered in arm and hand muscles (mDEL, mBB and mADM) as 
well as in the paravertebral musculature of thoracic region 
(mPV) more frequently (Figure 4). 
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Fig. 2 – Distribution of diagnostic categories by using 
the rEE or AS criteria according to the forms of the 
disease, spinal vs. bulbar according to the times of 
evaluation. 
Marks are the same as in Fig. 1 (A – 3 months;  
B – 6 months; C – 9 months; D – 12 months),  
so as abbreviations 
(POSS – possibly; PROB – probably; DEF – definitely). 
 
 
Finally, we tried to determine whether the degree of 
functional deficits measured by the FS in the patients who 
achieved the criteria of diagnosis by using the rEE or AS was 
different, which proved to be true only for the study “break-
point” – the third examination at the sixth month of monitor-
ing when the FS median of the AS was 34, or 30.5 of the rEE 
(p = 0.017). 
 
Fig. 3 – Representation of affected 2 or more body re-
gions, in the categories of probable and definite diagnosis 
of ALS and according to positive EMG findings as corre-
lates of PMN lesions. The abscissa includes the times of 
evaluation in months. 
*p < 0.05 (indicate the level of statistical significance); REE – 






The key finding of this prospective study refers to the 
time required to make a definite diagnosis of ALS, which, by 
using the AS criteria, is shortened on average for less than 3 
months. By using the AS criteria the definite diagnosis is 
made on average 9.81 ± 1.81 months from the initial exami-
nation, while in the period of 12 months from the initial ex-
amination none of the patients were diagnosed with defini-
tive ALS by using the rEE criteria. The difference between 
this study and previous similar ones refers to the absence of 
monitoring the evolution and contribution of the criteria dur-
ing the longitudinal observation of patients. 
Namely, the diagnosis of amyotrophic lateral sclerosis 
significantly complicates the complex clinical picture with 
numerous overlappings clinical presentations with other dis-
eases of the peripheral motor neuron as well as the absence 
of a reliable biological marker. Therefore, the diagnostic pro-
tocol requires both the clinical and electrophysiological signs 
of the disease, which eventually resulted in three (AS) or 
four (rEE) categories of diagnosis among which the reliabil-
ity increases with a number of body regions. 
Therefore, significant acceptance of electrophysiologi-
cal signs of denervation activity extends the possibility of de-
termining the affected body region from which the findings 
arose in our and similar studies. 
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Fig. 4 – Temporal and spatial distribution of the frequency of denervation activity in patients  
with amyotrophic lateral sclerosis. 
Fib – fibrillation; PDP – progressive denervation; FAS – fasciculations. 
mMEN – m. mentalis; MDEL – m. deltoideus; mBB – m. biceps brachii; mAPB – m. abductor pollicis trevis;  
mADM – abductor digiti minimi; mVL – m. rastus lateralis;  mTA – m. tibialis anterior; mEDB – m. extensor digitorum brevis; 
mFHB – m. flexor mallucis brevis. 
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The findings in our study are slightly weaker in com-
parison to the study of Okita et al. 9, since in their study the 
disease was diagnosed about 6 months earlier by using the 
AS criteria, but if the time was measured from the onset of 
symptoms. This difference may be partly due to the known 
effects of a relative delay between the onset of symptoms 
and refers to the tertiary center 10 in our study (Banja Luka, 
the Republic of Srpska), which was 10.2 ± 4.5 months. 
Furthermore, after 3 examinations (6 months after en-
tering the study), 28 of 30 patients (96%) met the AS criteria 
for probable or definite diagnosis, contrary to 33.3% when 
applying the rEE criteria. Also, using the AS criteria did not 
result in the loss of specificity, while the sensitivity was im-
proved in categories of probable and definite diagnosis of 
ALS to 6.7% in the third month by using the rEE, contrary to 
20% by using the AS. Moreover, the AS criteria provided the 
sensitivity of 100% for the mentioned above diagnostic cate-
gories in the ninth month of the monitoring, while the sensi-
tivity according to the rEE in the twelfth month was only 
60%. This is consistent with findings of de Carvalho and 
Swash 11 in one of the first publications dealing with similar 
issue, but at the same time, which is significantly better than 
some other studies 12, 13.  However, regarding the two last 
studies, it is necessary to emphasise that it is difficult to 
make the direct comparison due to the methodological dif-
ferences; the study of Noto et al. 12 was about an ethnic 
group of Asians, while in the study of Boekestein et al. 13, the 
design was a retrospective study. In addition to that, fewer 
muscles were examined electromyographically, which could 
certainly influence the sensitivity of the approach. 
The assumption that a set of the AS criteria is particularly 
sensitive to defining the category of the disease in the patients 
with bulbar form 12–14 was not confirmed in our case probably 
due to the relatively small number of examinees, since only 13 
patients with ALS suffered the bulbar form of the disease. 
In terms of detecting the denervation activity in general, 
the key point in the AS approach refers to the acceptance of 
specific types of the fasciculations, which are complex and 
unstable, as equivalent to current denervation changes 14. 
However, it is necessary to emphasize that the fasciculations, 
at the same time, are not the specific occurrence in ALS, but 
they can be seen extensively in other diseases of the periph-
eral motor neuron as poliomyelitis, chronic inflammatory 
demyelinating polyneuropathy, multifocal motor neuropa-
thy 15. Regarding the mechanism of the genesis of fascicula-
tions, it is now known that the fasciculations can occur at any 
level of a peripheral motor neuron, and the complex fascicu-
lations are particularly frequent in the region of distal axon 
arborisation 16.  There is an observation in patients with ALS 
that the fasciculations more often occur in an early phase of 
the disease when the muscular strength is relatively pre-
served. However, eliminating carefully other diseases and by 
the electrophysiological examination, the importance is given to 
fasciculations in early diagnosis of ALS, so de Carvalho and 
Swash 17 fasciculation as “very early marker of ALS”. 
This research showed that already after six months of 
monitoring using the AS criteria, more EMG affected re-
gions can be detected, which is consistent with the research 
of Schrooten et al. 18 who showed that about half of the pa-
tients (46.4%) have for at least one more affected region by 
using the AS criteria in relation to the patients categorised in 
accordance with the El Escorial criteria. 
Having in mind that there are no strict protocols of elec-
trophysiological evaluation related to the number of muscle 
examinations, or their selection by additional analysis we 
tried to provide commentary on the significance of this issue. 
In our sample, fibrillations and PSW are particularly often 
registered in mBB and mADM in upper extremities in only 2 
examinations in a row, where the ADM showed somewhat 
more frequent presence of fasciculations.  Contrary to this, 
the analysis of the examination of lower extremity muscles 
showed the particular importance of the small muscles of the 
feet (mEDB and mFHB) in detecting fasciculations. 
In summary, prospectively analyzing the use of new AS 
criteria for the diagnosis of amyotrophic lateral sclerosis, the 
preservation of specificity is confirmed, with the additional 
increase in the sensitivity of this approach. A study like this 
does not represent a special affirmation of electrophysiologi-
cal evaluation, having in mind that the approach is unavoid-
able was derived from the Lambert criteria. However, the AS 
criteria affirm a different importance of electrophysiological 
indicators enabling a faster determination of the categories of 
definite diagnosis and at the same time better accessibility to 





Application of the AS criteria improve the achievement of 
a category of probable or definite diagnosis of ALS by 2.7 
months earlier compared to the rEE. This outcome is 
particularly affected by a higher frequency of positive EMG fin-
dings, when the AS criteria were employed. Early determination 
of diagnosis provides the better perspective and more frequent 
participation of ALS patients in the pharmacotherapy studies in-
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